Wanbang Biopharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WANBANG BIOPHARMS, and what generic and branded alternatives to WANBANG BIOPHARMS drugs are available?
WANBANG BIOPHARMS has two approved drugs.
Drugs and US Patents for Wanbang Biopharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wanbang Biopharms | LEFLUNOMIDE | leflunomide | TABLET;ORAL | 077087-001 | Sep 13, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Wanbang Biopharms | LEFLUNOMIDE | leflunomide | TABLET;ORAL | 077087-002 | Sep 13, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Wanbang Biopharms | CARISOPRODOL | carisoprodol | TABLET;ORAL | 081025-001 | Apr 13, 1989 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.